Solana Company (HSDT)
Automate Your Wheel Strategy on HSDT
With Tiblio's Option Bot, you can configure your own wheel strategy including HSDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSDT
- Rev/Share 119.6269
- Book/Share 2443.6334
- PB 0.0032
- Debt/Equity 0.0
- CurrentRatio 4.323
- ROIC -2.3899
- MktCap 58636632.0
- FreeCF/Share -4639.9027
- PFCF -5.1247
- PE -0.0009
- Debt/Assets 0.0
- DivYield 0
- ROE -6.9993
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Solana Company Executive Chairman's Message: October 20th, 2025
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ: HSDT) released the following letter from the Executive Chairman:
Read More
Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings
Published: October 10, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Solana Company (NASDAQ:HSDT) (“HSDT” or “the Company”), formerly known as Helius Medical Technologies, Inc., today announced it has selected BitGo, the digital asset infrastructure company, to serve as a custodian for the Company's holdings of SOL, the native asset of the Solana Network. The partnership supports Solana Company's digital asset treasury strategy as it continues to build its position in SOL. “Our collaboration with BitGo reinforces HSDT's commitment to a.
Read More
Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company
Published: September 18, 2025 by: PRNewsWire
Sentiment: Neutral
Preeminent SOL-backed treasury vehicle - with potential to raise over $1.25 billion aggregate gross proceeds - unlocks capital markets to accelerate Solana's growth The financing drew participation from leading investors across traditional finance and crypto, including Big Brain Holdings, Avenir, SinoHope, FalconX, Arrington Capital, Animoca Brands, Aspen Digital, Borderless, Laser Digital, HashKey Capital, and Republic Digital NEWTOWN, Pa. , Sept. 18, 2025 /PRNewswire/ -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) ("Helius" or the "Company") today announced that it has closed its previously announced private placement offering (the "Offering") of common stock and stapled warrants to purchase common stock (and/or pre-funded …
Read More
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
Published: July 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome from the PoNS (Portable Neuromodulation Stimulator) Stroke Registrational Program (SRP) supporting a planned FDA submission seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under the current Breakthrough Device Designation.
Read More
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
Published: June 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and warrants to purchase up to 2,768,600 shares of common stock, at a combined public offering price of $3.27 per share and accompanying warrants.
Read More
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
Published: May 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement
Read More
Helius Medical Technologies Announces Reverse Stock Split
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-15 reverse split of its Class A common stock, par value $0.001 (“common stock”), effective at 5:00 pm Eastern time on May 1, 2025.
Read More
About Solana Company (HSDT)
- IPO Date 2014-06-27
- Website https://solana.com
- Industry Medical - Devices
- CEO Dane Carl Andreeff
- Employees 21